ConductScience.org, home

Paper2643772

Comparison of high-dose with low-dose subcutaneous heparin to prevent left ventricular mural thrombosis in patients with acute transmural anterior myocardial infarction.

Turpie AG and 9 others. N Engl J Med, 1989. Cited by 283 papers, by iCite.

Cite this record

ConductScience Library. Comparison of high-dose with low-dose subcutaneous heparin to prevent left ventricular mural thrombosis in patients with acute transmural anterior myocardial infarction. Papers, record 2643772. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2643772

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Comparison of high-dose with low-dose subcutaneous heparin to prevent left ventricular mural thrombosis in patients with acute transmural anterior myocardial infarction.
PubMed
Journal
N Engl J Med
PubMed
Year
1989
PubMed
Publication types
Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
283
iCite
Relative citation ratio, by iCite
10.1
iCite
Revised in PubMed
2007-11-15
PubMed

Authors10

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Turpie AGA G
2Robinson JGJ G
3Doyle DJD J
4Mulji ASA S
5Mishkel GJG J
6Sealey BJB J
7Cairns JAJ A
8Skingley LL
9Hirsh JJ
10Gent MM

Source PubMed

Download CSV of authors

Topics16

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Coronary DiseaseMajor topic
Coronary ThrombosisMajor topic
HeparinMajor topic
Myocardial InfarctionMajor topic
Aged
Clinical Trials as Topic
Double-Blind Method
Echocardiography
Female
Follow-Up Studies
Hemorrhage
Humans
Injections, Subcutaneous
Male
Partial Thromboplastin Time
Random Allocation

Source PubMed

Download CSV of topics

Trials3

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's recordSource
NCT03415386Optimized Antithrombotic Therapy of Acute Myocardial Infarction With Left Ventricular Mural ThrombusBackgroundClinicalTrials.gov
NCT04829825The "MyoThrombus" StudyBackgroundClinicalTrials.gov
NCT05006677Effectiveness and Safety of Different Antithrombotic Therapy for the Treatment of Ventricular ThrombusBackgroundClinicalTrials.gov

Download CSV of trials

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Comment in2747763Heparin for mural thrombosis in anterior myocardial infarction.https://conductscience.org/library/papers/2747763

Source PubMed

Download CSV of comments and corrections

Cited by53

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 283 citations.

PMIDTitleJournalYearIn PapersSource
39938942Advancing clinical management of left ventricular thrombosis: prevention, detection and treatment modalities in the modern era.Heart2025https://conductscience.org/library/papers/39938942PubMed
39850087Carbon dots with red emission as nanoprobe for sensing of heparin in biofluids and pharmaceutical samples.RSC Adv2025https://conductscience.org/library/papers/39850087PubMed
39076895A Meta-Analysis Comparing Different Oral Anticoagulation for the Treatment of Ventricular Thrombus.Rev Cardiovasc Med2022https://conductscience.org/library/papers/39076895PubMed
35685496Different Oral Antithrombotic Therapy for the Treatment of Ventricular Thrombus: An Observational Study from 2010 to 2019.Int J Clin Pract2022https://conductscience.org/library/papers/35685496PubMed
34420077Rivaroxaban versus Vitamin K Antagonists (warfarin) based on the triple therapy for left ventricular thrombus after ST-Elevation myocardial infarction.Heart Vessels2022https://conductscience.org/library/papers/34420077PubMed
33850917Management of left ventricular thrombus: a narrative review.Ann Transl Med2021https://conductscience.org/library/papers/33850917PubMed
29985433Comparison of Systematic Ticagrelor-Based Dual Antiplatelet Therapy to Selective Triple Antithrombotic Therapy for Left Ventricle Dysfunction Following Anterior STEMI.Sci Rep2018https://conductscience.org/library/papers/29985433PubMed
29886450
Accuracy, reproducibility and costs of different laboratory assays for the monitoring of unfractionated heparin in clinical practice: a prospective evaluation study and survey among Swiss institutions.
BMJ Open2018https://conductscience.org/library/papers/29886450PubMed
28396990Incidence and outcomes of early left ventricular thrombus following ST-elevation myocardial infarction treated with primary percutaneous coronary intervention.Clin Res Cardiol2017https://conductscience.org/library/papers/28396990PubMed
28197053Large In-transient Left Ventricular Thrombus due to Anabolic Steroid-induced Cardiomyopathy.Indian J Crit Care Med2017https://conductscience.org/library/papers/28197053PubMed
27766063Aspirin plus tirofiban inhibit the thrombosis induced by Russell's viper venom.Thromb J2016https://conductscience.org/library/papers/27766063PubMed
27698506Comparison of Time to Therapeutic aPTT in Patients Who Received Continuous Unfractionated Heparin After Implementation of Pharmacy-wide Intervention Alerts.Hosp Pharm2016https://conductscience.org/library/papers/27698506PubMed
27413043Ischemic Stroke Risk After Acute Coronary Syndrome.J Am Heart Assoc2016https://conductscience.org/library/papers/27413043PubMed
26417910Incidence and Predictors of Left Ventricular Thrombus After Primary Percutaneous Coronary Intervention for Anterior ST-Segment Elevation Myocardial Infarction.Clin Cardiol2015https://conductscience.org/library/papers/26417910PubMed
26365955Clinical Characteristics and Risk Factors of Left Ventricular Thrombus after Acute Myocardial Infarction: A Matched Case-control Study.Chin Med J (Engl)2015https://conductscience.org/library/papers/26365955PubMed
24421495High-Risk Non-ST Elevation Acute Coronary Syndrome Outcomes in Patients Treated with Unfractionated Heparin Monitored Using Anti-Xa Concentrations Versus Activated Partial Thromboplastin Time.Hosp Pharm2013https://conductscience.org/library/papers/24421495PubMed
23730016Electrochemical assay of heparin to monitor anticoagulation action in cardiovascular patients.Indian J Hematol Blood Transfus2012https://conductscience.org/library/papers/23730016PubMed
23687625Anticoagulants: A Review of the Pharmacology, Dosing, and Complications.Curr Emerg Hosp Med Rep2013https://conductscience.org/library/papers/23687625PubMed
23584757Mobile left ventricular thrombus in left ventricular dysfunction: case report and review of literature.Clin Res Cardiol2013https://conductscience.org/library/papers/23584757PubMed
23151669Left ventricular thrombus formation after acute myocardial infarction.Heart2012https://conductscience.org/library/papers/23151669PubMed

See all 53 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/2643772

GET https://conductscience.org/api/papers/v1/2643772/cited_by?page=2